miR-135b Contributes to the Radioresistance by Targeting GSK3β in Human Glioblastoma Multiforme Cells

Radioresistance remains a major challenge in the treatment of glioblastoma multiforme (GBM). Recent data strongly suggests the important role of miRNAs in cancer progression and therapeutic response. Here, we have established a radioresistant human GBM cell line U87R derived from parental U87 and found miR-135b expression was upregulated in U87R cells. miR-135b knockdown reversed radioresistance of U87R cells, and miR-135b overexpression enhanced radioresistance of U87 cells. Mechanically, bioinformatics analysis combined with experimental analysis demonstrated GSK3 beta (Glycogen synthase kinase 3 beta) was a novel direct target of miR-135b. Moreover, GSK3 beta protein expression was downregulated in U87R cells and restored expression of GSK3 beta increased radiosensitivity of U87R cells. In addition, clinical data indicated that the expression of miR-135b or GSK3 beta was significantly association with IR resistance of GBM samples. Our findings suggest miR-135b is involved in the radioresistance of human GBM cells and miR-135b-GSK3 beta axis may be a novel candidate for developing rational therapeutic strategies for human GBM treatment.